Literature DB >> 22148823

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex.

M K Moi, C F Meares, S J Denardo.   

Abstract

Entities:  

Year:  1988        PMID： 22148823     DOI： 10.1021/ja00226a063

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  10 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  Ionizable Calixarene-Crown Ethers with High Selectivity for Radium over Light Alkaline Earth Metal Ions.

Authors:  Xiaoyuan Chen; Min Ji; Darrell R Fisher; Chien M Wai
Journal:  Inorg Chem       Date:  2009-11-15       Impact factor: 5.165

Review 3.  Bifunctional chelates for metal nuclides.

Authors:  M W Brechbiel
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-11-28       Impact factor: 2.346

4.  Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.

Authors:  Marc Hens; Ganesan Vaidyanathan; Phil Welsh; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2009-02       Impact factor: 2.408

Review 5.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

6.  Labelling monoclonal antibodies with yttrium-90.

Authors:  S J Mather; D M Tolley; G W White
Journal:  Eur J Nucl Med       Date:  1989

7.  Pretargeted radioimmunotherapy for hematologic and other malignancies.

Authors:  Roland B Walter; Oliver W Press; John M Pagel
Journal:  Cancer Biother Radiopharm       Date:  2010-04       Impact factor: 3.099

8.  (111)In- and (203)Pb-Labeled Cyclic RGD Peptide Conjugate as an α(v)β(3) Integrin-Binding Radiotracer.

Authors:  Kido Nwe; Young-Seung Kim; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  J Labelled Comp Radiopharm       Date:  2012-09-05       Impact factor: 1.921

9.  Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy.

Authors:  W H Bakker; W A Breeman; M E van der Pluijm; M de Jong; T J Visser; E P Krenning
Journal:  Eur J Nucl Med       Date:  1996-07

Review 10.  An overview of radioimmunotherapy.

Authors:  A Maraveyas; A A Epenetos
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.